Langsung ke konten utama

Adventures Inward Alicante

OHIM Second Board allows registration of EEC ADVENTURES IN ALICANTE
OHIM Second Board allows registration of EEC

is even then recovering from the stupor of reading a recent OHIM Board of Appeal decision did non bar the term EEC – European Electronic Confidence from beingness registered every bit a score for goods as well as services inward Classes 9, 35, 36, 38 as well as 41. The determination is solely available inward French, but the IPKat has pieced it together amongst the manage of Babelfish.

couldn't believe his eyes

The examiner turned the score downwards every bit it conflicted amongst Art 6ter of the Paris Convention but the Board has annulled her determination as well as has remitted the representative for re-examination. The Board felt that the presence of the term European Electronic Confidence would take whatsoever possibility of confusion amongst the EEC every bit nosotros know it. Moreover, consumers would know the EEC’s purpose inward telecoms as well as the other services applied for was legislative, rather than offering such services.


Merpel says that this simply goes to demo that he who dares, wins (sometimes).


OHIM backs Anheuser Busch
OHIM Second Board allows registration of EEC ADVENTURES IN ALICANTE
An OHIM Board of Appeal has recognised Anheuser-Busch’s correct to register BUD every bit a CTM according to Chron.com. The total text of the determination isn’t available on the OHIM website but an excerpt provided yesteryear Anheuser Busch suggests that the fundamental element was that BUD wouldn’t survive perceived every bit a geographical indicator.

awaits the inevitable appeal…

Komentar

Postingan populer dari blog ini

Something To Read This Weekend

July-August Copyright World The electrical flow termination of Informa's colourful Copyright World has only reached the IPKat. The comprehend story is Google v Rest of the World - at least, it must experience that means to the giant moneymaker every bit it seeks to induce got on a vast array of vested interests inwards mature markets as well as technologies amongst its controversial Library Project. bets that this topic volition attain saturation point, replacing fifty-fifty P2P filesharing every bit the boringly predictable PhD thesis topic that all candidates desire to write. Full listing of contents here . Merpel's Must-Read : "Into the Honey Trap?", where the Copyright Terminator meets Winnie the Pooh. July-August MIP The July-August termination of Euromoney's Managing Intellectual Property lists the 50 close influential IP personalities of the year. Alas, afterwards the excitement of making the listing concluding fourth dimension round, the IPKat has been ...

No Prophylactic Trend To Intermission Up; Latest Ecdr

No rubber agency to interruption up This morning time the IPKat carried a greenback on Scansafe Ltd 5 Messagelabs Ltd , a Chancery Division conclusion from Mr Justice Patten which was noted on Lawtel. has since received an electronic mail from solicitors acting on behalf of Scansafe, informing him that the Lawtel greenback erroneously stated that Scansafe's application for injunctive relief was dismissed. Lawtel has since withdrawn its greenback in addition to the IPKat, non wishing to mislead his readers, has removed his greenback on the example too. Latest ECDR Issue four of the Sweet & Maxwell bimonthly European Copyright in addition to Design Reports has at i time been published. Cases available inwards English linguistic communication inwards this lawsuit include * L'Oréal SA 5 Bellure NV (Cour d'appel de Paris), on the protection of scents inwards French Republic every bit authors' works; * PlayStation (Tribunal of Bolzano, Italy), on the seizure of modern...

Gsk Gets That Ill Feeling Equally Antibiotic Patents Come Across An Early On Death

GlaxoSmithKline ( lost its activity to forbid Swiss fellowship Novartis making in addition to selling inexpensive generic versions of Augmentin , GSK's leading antibiotic. GSK’s proceedings were aimed both against Novartis in addition to its generic company, Geneva Pharmaceuticals . The United States Court of Appeals for the Federal Circuit ruled inwards favour of Novartis in addition to Geneva slow on Friday, upholding Geneva's claim that vii of GSK's patents for the drug were "improper in addition to should non bring been used to extend patent protection for [GSK's] product". Novartis in addition to Geneva surprised the marketplace inwards 2002 when it launched a generic version of Augmentin. The launch came afterwards an unexpected United States legal determination inwards May 2002 that a position out of GSK's patents for Augmentin were invalid. GSK spent over a twelvemonth fighting the determination only the master copy ruling has straight off bee...